Statistics from Altmetric.com
- hormone replacement therapy
- breast neoplasms
- coronary disease
- cerebrovascular accident
- venous thrombosis
- colorectal neoplasms
Q In perimenopausal and postmenopausal women, does long term use of hormone therapy (HT) affect the risk of death, vascular disease, cancer, dementia, and other chronic diseases?
Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Endocrine ★★★★★★☆ Geriatrics ★★★★★★☆ Gynaecology ★★★★★★★
Medline, EMBASE/Excerpta Medica, Biological Abstracts, Cochrane Central Register of Controlled Trials, and Cochrane Menstrual Disorders and Subfertility Group Trials Register (to November 2004); UK National Research Register and registers from the UK National Health Service Centre for Reviews and Dissemination (to January 2004); reference lists of relevant articles; and pharmaceutical companies.
Study selection and assessment:
randomised, double blind, placebo controlled trials (RCTs) that evaluated the effect of long term HT use (⩾1 y) on death or serious chronic diseases in perimenopausal or postmenopausal women. HT consisted of oestrogen, alone or combined with progestogen, administered by oral, transdermal, subcutaneous, or intranasal routes.
mortality, heart disease, …
For correspondence: Dr C M Farquhar, University of Auckland, New Zealand.
Source of funding: no external funding.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.